The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
CRM in Pharma and Biotech Software-Global Market Insights and Sales Trends 2024
Synopsis
CRM in Pharma and Biotech Software is a type of CRM software that can help users to manage competitive intelligence and life sciences data.
The global CRM in Pharma and Biotech Software market size is expected to reach US$ 1777.9 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of CRM in Pharma and Biotech Software in various end use industries. The expanding demands from the Large Enterprises and SMEs, are propelling CRM in Pharma and Biotech Software market. Cloud Based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Web Based segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRM in Pharma and Biotech Software, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRM in Pharma and Biotech Software market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRM in Pharma and Biotech Software market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRM in Pharma and Biotech Software sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRM in Pharma and Biotech Software covered in this report include Inova Software, Veeva Systems, Aurea, Oracle, AKA Enterprise Solutions, Cirrius, Close-Up International, Euris and Indegene, etc.
The global CRM in Pharma and Biotech Software market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Inova Software
Veeva Systems
Aurea
Oracle
AKA Enterprise Solutions
Cirrius
Close-Up International
Euris
Indegene
Infonis International
Interactive Medica
Ivy
Media-Soft
Navicon
Pitcher
Prolifiq
QuintilesIMS
StayinFront
Synergistix
Trueblue
Global CRM in Pharma and Biotech Software market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRM in Pharma and Biotech Software market, Segment by Type:
Cloud Based
Web Based
Global CRM in Pharma and Biotech Software market, by Application
Large Enterprises
SMEs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRM in Pharma and Biotech Software companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
CRM in Pharma and Biotech Software is a type of CRM software that can help users to manage competitive intelligence and life sciences data.
The global CRM in Pharma and Biotech Software market size is expected to reach US$ 1777.9 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029. The market is mainly driven by the significant applications of CRM in Pharma and Biotech Software in various end use industries. The expanding demands from the Large Enterprises and SMEs, are propelling CRM in Pharma and Biotech Software market. Cloud Based, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Web Based segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for CRM in Pharma and Biotech Software, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global CRM in Pharma and Biotech Software market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global CRM in Pharma and Biotech Software market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, CRM in Pharma and Biotech Software sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of CRM in Pharma and Biotech Software covered in this report include Inova Software, Veeva Systems, Aurea, Oracle, AKA Enterprise Solutions, Cirrius, Close-Up International, Euris and Indegene, etc.
The global CRM in Pharma and Biotech Software market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Inova Software
Veeva Systems
Aurea
Oracle
AKA Enterprise Solutions
Cirrius
Close-Up International
Euris
Indegene
Infonis International
Interactive Medica
Ivy
Media-Soft
Navicon
Pitcher
Prolifiq
QuintilesIMS
StayinFront
Synergistix
Trueblue
Global CRM in Pharma and Biotech Software market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global CRM in Pharma and Biotech Software market, Segment by Type:
Cloud Based
Web Based
Global CRM in Pharma and Biotech Software market, by Application
Large Enterprises
SMEs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of CRM in Pharma and Biotech Software companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of CRM in Pharma and Biotech Software
1.1 CRM in Pharma and Biotech Software Market Overview
1.1.1 CRM in Pharma and Biotech Software Product Scope
1.1.2 CRM in Pharma and Biotech Software Market Status and Outlook
1.2 Global CRM in Pharma and Biotech Software Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global CRM in Pharma and Biotech Software Market Size by Region (2018-2029)
1.4 Global CRM in Pharma and Biotech Software Historic Market Size by Region (2018-2023)
1.5 Global CRM in Pharma and Biotech Software Market Size Forecast by Region (2024-2029)
1.6 Key Regions, CRM in Pharma and Biotech Software Market Size (2018-2029)
1.6.1 North America CRM in Pharma and Biotech Software Market Size (2018-2029)
1.6.2 Europe CRM in Pharma and Biotech Software Market Size (2018-2029)
1.6.3 Asia-Pacific CRM in Pharma and Biotech Software Market Size (2018-2029)
1.6.4 Latin America CRM in Pharma and Biotech Software Market Size (2018-2029)
1.6.5 Middle East & Africa CRM in Pharma and Biotech Software Market Size (2018-2029)
2 CRM in Pharma and Biotech Software Market by Type
2.1 Introduction
2.1.1 Cloud Based
2.1.2 Web Based
2.2 Global CRM in Pharma and Biotech Software Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global CRM in Pharma and Biotech Software Historic Market Size by Type (2018-2023)
2.2.2 Global CRM in Pharma and Biotech Software Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America CRM in Pharma and Biotech Software Revenue Breakdown by Type (2018-2029)
2.3.2 Europe CRM in Pharma and Biotech Software Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific CRM in Pharma and Biotech Software Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America CRM in Pharma and Biotech Software Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa CRM in Pharma and Biotech Software Revenue Breakdown by Type (2018-2029)
3 CRM in Pharma and Biotech Software Market Overview by Application
3.1 Introduction
3.1.1 Large Enterprises
3.1.2 SMEs
3.2 Global CRM in Pharma and Biotech Software Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global CRM in Pharma and Biotech Software Historic Market Size by Application (2018-2023)
3.2.2 Global CRM in Pharma and Biotech Software Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America CRM in Pharma and Biotech Software Revenue Breakdown by Application (2018-2029)
3.3.2 Europe CRM in Pharma and Biotech Software Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific CRM in Pharma and Biotech Software Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America CRM in Pharma and Biotech Software Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa CRM in Pharma and Biotech Software Revenue Breakdown by Application (2018-2029)
4 CRM in Pharma and Biotech Software Competition Analysis by Players
4.1 Global CRM in Pharma and Biotech Software Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in CRM in Pharma and Biotech Software as of 2022)
4.3 Date of Key Players Enter into CRM in Pharma and Biotech Software Market
4.4 Global Top Players CRM in Pharma and Biotech Software Headquarters and Area Served
4.5 Key Players CRM in Pharma and Biotech Software Product Solution and Service
4.6 Competitive Status
4.6.1 CRM in Pharma and Biotech Software Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Inova Software
5.1.1 Inova Software Profile
5.1.2 Inova Software Main Business
5.1.3 Inova Software CRM in Pharma and Biotech Software Products, Services and Solutions
5.1.4 Inova Software CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.1.5 Inova Software Recent Developments
5.2 Veeva Systems
5.2.1 Veeva Systems Profile
5.2.2 Veeva Systems Main Business
5.2.3 Veeva Systems CRM in Pharma and Biotech Software Products, Services and Solutions
5.2.4 Veeva Systems CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.2.5 Veeva Systems Recent Developments
5.3 Aurea
5.3.1 Aurea Profile
5.3.2 Aurea Main Business
5.3.3 Aurea CRM in Pharma and Biotech Software Products, Services and Solutions
5.3.4 Aurea CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.3.5 Oracle Recent Developments
5.4 Oracle
5.4.1 Oracle Profile
5.4.2 Oracle Main Business
5.4.3 Oracle CRM in Pharma and Biotech Software Products, Services and Solutions
5.4.4 Oracle CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.4.5 Oracle Recent Developments
5.5 AKA Enterprise Solutions
5.5.1 AKA Enterprise Solutions Profile
5.5.2 AKA Enterprise Solutions Main Business
5.5.3 AKA Enterprise Solutions CRM in Pharma and Biotech Software Products, Services and Solutions
5.5.4 AKA Enterprise Solutions CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.5.5 AKA Enterprise Solutions Recent Developments
5.6 Cirrius
5.6.1 Cirrius Profile
5.6.2 Cirrius Main Business
5.6.3 Cirrius CRM in Pharma and Biotech Software Products, Services and Solutions
5.6.4 Cirrius CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.6.5 Cirrius Recent Developments
5.7 Close-Up International
5.7.1 Close-Up International Profile
5.7.2 Close-Up International Main Business
5.7.3 Close-Up International CRM in Pharma and Biotech Software Products, Services and Solutions
5.7.4 Close-Up International CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.7.5 Close-Up International Recent Developments
5.8 Euris
5.8.1 Euris Profile
5.8.2 Euris Main Business
5.8.3 Euris CRM in Pharma and Biotech Software Products, Services and Solutions
5.8.4 Euris CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.8.5 Euris Recent Developments
5.9 Indegene
5.9.1 Indegene Profile
5.9.2 Indegene Main Business
5.9.3 Indegene CRM in Pharma and Biotech Software Products, Services and Solutions
5.9.4 Indegene CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.9.5 Indegene Recent Developments
5.10 Infonis International
5.10.1 Infonis International Profile
5.10.2 Infonis International Main Business
5.10.3 Infonis International CRM in Pharma and Biotech Software Products, Services and Solutions
5.10.4 Infonis International CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.10.5 Infonis International Recent Developments
5.11 Interactive Medica
5.11.1 Interactive Medica Profile
5.11.2 Interactive Medica Main Business
5.11.3 Interactive Medica CRM in Pharma and Biotech Software Products, Services and Solutions
5.11.4 Interactive Medica CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.11.5 Interactive Medica Recent Developments
5.12 Ivy
5.12.1 Ivy Profile
5.12.2 Ivy Main Business
5.12.3 Ivy CRM in Pharma and Biotech Software Products, Services and Solutions
5.12.4 Ivy CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.12.5 Ivy Recent Developments
5.13 Media-Soft
5.13.1 Media-Soft Profile
5.13.2 Media-Soft Main Business
5.13.3 Media-Soft CRM in Pharma and Biotech Software Products, Services and Solutions
5.13.4 Media-Soft CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.13.5 Media-Soft Recent Developments
5.14 Navicon
5.14.1 Navicon Profile
5.14.2 Navicon Main Business
5.14.3 Navicon CRM in Pharma and Biotech Software Products, Services and Solutions
5.14.4 Navicon CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.14.5 Navicon Recent Developments
5.15 Pitcher
5.15.1 Pitcher Profile
5.15.2 Pitcher Main Business
5.15.3 Pitcher CRM in Pharma and Biotech Software Products, Services and Solutions
5.15.4 Pitcher CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.15.5 Pitcher Recent Developments
5.16 Prolifiq
5.16.1 Prolifiq Profile
5.16.2 Prolifiq Main Business
5.16.3 Prolifiq CRM in Pharma and Biotech Software Products, Services and Solutions
5.16.4 Prolifiq CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.16.5 Prolifiq Recent Developments
5.17 QuintilesIMS
5.17.1 QuintilesIMS Profile
5.17.2 QuintilesIMS Main Business
5.17.3 QuintilesIMS CRM in Pharma and Biotech Software Products, Services and Solutions
5.17.4 QuintilesIMS CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.17.5 QuintilesIMS Recent Developments
5.18 StayinFront
5.18.1 StayinFront Profile
5.18.2 StayinFront Main Business
5.18.3 StayinFront CRM in Pharma and Biotech Software Products, Services and Solutions
5.18.4 StayinFront CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.18.5 StayinFront Recent Developments
5.19 Synergistix
5.19.1 Synergistix Profile
5.19.2 Synergistix Main Business
5.19.3 Synergistix CRM in Pharma and Biotech Software Products, Services and Solutions
5.19.4 Synergistix CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.19.5 Synergistix Recent Developments
5.20 Trueblue
5.20.1 Trueblue Profile
5.20.2 Trueblue Main Business
5.20.3 Trueblue CRM in Pharma and Biotech Software Products, Services and Solutions
5.20.4 Trueblue CRM in Pharma and Biotech Software Revenue (US$ Million) & (2018-2023)
5.20.5 Trueblue Recent Developments
6 North America
6.1 North America CRM in Pharma and Biotech Software Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe CRM in Pharma and Biotech Software Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific CRM in Pharma and Biotech Software Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America CRM in Pharma and Biotech Software Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa CRM in Pharma and Biotech Software Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 CRM in Pharma and Biotech Software Market Dynamics
11.1 CRM in Pharma and Biotech Software Industry Trends
11.2 CRM in Pharma and Biotech Software Market Drivers
11.3 CRM in Pharma and Biotech Software Market Challenges
11.4 CRM in Pharma and Biotech Software Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
